Rheumatic fever: From pathogenesis to vaccine perspectives

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Citação
Guilherme, L.; Branco, C. E.; De Barros, S. F.; Kalil, J.. Rheumatic fever: From pathogenesis to vaccine perspectives. In: . Translational Autoimmunity: Volume 6: Advances in Autoimmune Rheumatic Diseases: ELSEVIER, 2023. p.47-59.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rheumatic fever (RF) is considered a model of autoimmune disease due to untreated throat infection by S. pyogenes that affects children and teenagers. The autoimmune process is believed to be the basis of all of the clinical manifestations; for instance, arthritis by immune complex deposition, chorea by antibody binding to neuronal cells, skin and subcutaneous manifestations that are mediated by a delayed hypersensitivity reaction, and carditis that is caused by cross-reactive antibodies and T cells. This chapter presents an overview of the mechanisms leading to the tissue lesions, treatment, and future possibilities of a vaccine against S. pyogenes. © 2023 Elsevier Inc. All rights reserved.
Palavras-chave
Autoimmunity, HLA class II alleles, Rheumatic fever, T cells
Referências
  1. Muhamed B., Parks T., Sliwa K., Genetics of rheumatic fever and rheumatic heart disease, Nat. Rev. Cardiol, 17, 3, pp. 145-154, (2020)
  2. Burke J.B., Erythema marginatum, Arch. Dis. Child, 30, 152, pp. 359-365, (1955)
  3. Demiroren K., Yavuz H., Cam L., Oran B., Karaaslan S., Demiroren S., Sydenham’s chorea: a clinical follow-up, J. Child Neurol, 22, 5, pp. 550-554, (2007)
  4. Carapetis J.R., Acute rheumatic fever and rheumatic heart disease, Nat. Rev. Dis. Primers, 2, pp. 1-24, (2016)
  5. Szczygielska I., Hernik E., Kolodziejczyk B., Gazda A., Maslinska M., Gietka P., Rheumatic fever—new diagnostic criteria, Reumatologia, 56, 1, pp. 37-41, (2018)
  6. Gewitz M.H., Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography a scientific statement from the American Heart Association, Circulation, 131, pp. 1806-1818, (2015)
  7. Remeanyi B., World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline, Nat. Rev. Cardiol, 9, 5, pp. 297-309, (2012)
  8. The 2020 Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease, (2020)
  9. Carapetis J., Brown A., Maguire G., Walsh W., The Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease, (2012)
  10. Goyal P., Vijayvergiya R., Rheumatic fever and rheumatic heart disease, International Encyclopedia of Public Health, pp. 357-362, (2016)
  11. Braunwald E., Braunwald Heart Disease: A Textbook of Cardiovascular Medicine, (2018)
  12. New Zealand Guidelines for Rheumatic Fever Diagnosis, Management and Secondary Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease: 2014 Update, pp. 1-97, (2014)
  13. Watkins D.A., Rheumatic heart disease worldwide: JACC scientific expert panel, J. Am. Coll. Cardiol, 72, 12, pp. 1397-1416, (2018)
  14. Jaggi P., Rheumatic fever and postgroup-a streptococcal arthritis, Pediatr. Infect. Dis. J, 30, 5, pp. 424-425, (2011)
  15. Karthikeyan G., Guilherme L., Acute rheumatic fever, Lancet, 392, 10142, pp. 161-174, (2018)
  16. Risavi B.L., Iszkula E., Yost B., Sydenham’s chorea, J. Emerg. Med, 56, 6, pp. e119-e121, (2019)
  17. Swedo S.E., Sydenham’s chorea: physical and psychological symptoms of St Vitus dance, Pediatrics, 91, 4, pp. 706-713, (1993)
  18. Marc H., Gravallese E., Silman A., Smolen J., Weinblatt M., Weisman M., Rheumatology, (2018)
  19. Meira Z.M.A., Goulart E.M.A., Colosimo E.A., Mota C.C.C., Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents, Heart, 91, pp. 1019-1022, (2005)
  20. WHO Technical Report Series, (2004)
  21. Poonia A., Giridhara P., Sheoran D., Subcutaneous nodules in acute rheumatic fever, J. Pediatr, 213, (2019)
  22. The Australian Guideline for Prevention, Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease (2nd edition). Quick Reference Guides, (2014)
  23. da Silva C.H.M., Rheumatic fever: a multicenter study in the State of São Paulo, Rev. Hosp. Clin. Fac. Med. Sao Paulo, 54, 3, pp. 85-90, (1999)
  24. Stolerman G.H., Markowitz M., Taranta A., Wannamaker L.W., Whittemore R., Jones criteria (modified) for guidance in the diagnosis of rheumatic fever, Circulation, 32, 7, pp. 664-668, (1965)
  25. Seckeler M.D., Hoke T.R., The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease, Clin. Epidemiol, 3, pp. 67-84, (2011)
  26. Upton A., Bissessor L., Farrell E., Shulman S.T., Zheng X., Lennon D., Comparison of illumigene group A streptococcus assay with culture of throat swabs from children with sore throats in the New Zealand school-based rheumatic fever prevention program, J. Clin. Microbiol, 54, 1, pp. 153-156, (2016)
  27. Muthanna A., Salim H.S., Hamat R.A., Shamsuddin N.H., Zakariah S.Z., Clinical screening tools to diagnose group a streptococcal pharyngotonsillitis in primary care clinics to improve prescribing habits, Malays. J. Med. Sci, 25, 6, pp. 6-21, (2018)
  28. Arvind B., Ramakrishnan S., Rheumatic fever and rheumatic heart disease in children, Indian J. Pediatr, 87, 4, pp. 305-311, (2020)
  29. Cilliers A., Adler A.J., Saloojee H., Anti-inflammatory treatment for carditis in acute rheumatic fever, Cochrane Database Syst. Rev, 5, pp. 1-47, (2015)
  30. Beier K., Pratt D.P., Sydenham Chorea, (2020)
  31. Paz J.A., Silva C.A.A., Marques-Dias M.J., Randomized double-blind study with prednisone in Sydenham’s chorea, Pediatr. Neurol, 34, 4, pp. 264-269, (2006)
  32. Dean S.L., Singer H.S., Treatment of sydenham’s chorea: a review of the current evidence, Tremor Other Hyperkinet. Move, 7, pp. 1-13, (2017)
  33. Gerber M.A., Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease I, Circulation, 119, 11, pp. 1541-1551, (2009)
  34. Woods J.A., Katzenellenbogen J.M., Adherence to secondary prophylaxis among patients with acute rheumatic fever and rheumatic heart disease, Curr. Cardiol. Rev, 15, 3, pp. 239-241, (2019)
  35. De Dassel J.L., De Klerk N., Carapetis J.R., Ralph A.P., How many doses make a difference? An analysis of secondary prevention of rheumatic fever and rheumatic heart disease, J. Am. Heart Assoc, 7, 24, (2018)
  36. Osowicki J., Vekemans J., Kaslow D.C., Friede M.H., Kim J.H., Steer A.C., WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: report from a meeting held on 12–13 December 2016, Vaccine, 36, 24, pp. 3397-3405, (2018)
  37. Pastural E., Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I study, Vaccine, 38, 6, pp. 1384-1392, (2020)
  38. De Amicis K.M., Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes, Vaccine, 32, 32, pp. 4104-4110, (2014)
  39. Guilherme L., Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules, J. Biol. Chem, 286, 9, pp. 6989-6998, (2011)
  40. Guerino M.T., HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate, Vaccine, 29, 46, pp. 8250-8256, (2011)
  41. Postol E., Group a Streptococcus adsorbed vaccine: repeated intramuscular dose toxicity test in minipigs, Sci. Rep, 9, 1, pp. 1-12, (2019)